Impact of Harmonization by Doing HBD: Into the Second Decade - Mitchell Krucoff, MD, FSCAI

Target Audience

• Interventional Cardiologists
• Clinical Trial Investigators
• Medical Device Professionals

Session Name: Japan FDA: Japan - US Synergies In The Second Decade - Opening Perspectives

Track: Technology & Innovation

Learning Objectives

Updates on regulatory harmonisation and clinical trial design in the US & Japan

Other Components in this Moment